277 related articles for article (PubMed ID: 3262705)
21. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection.
DiNapoli JM; Murphy BR; Collins PL; Bukreyev A
Virol J; 2008 Sep; 5():105. PubMed ID: 18816384
[TBL] [Abstract][Full Text] [Related]
22. Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.
Rutigliano JA; Johnson TR; Hollinger TN; Fischer JE; Aung S; Graham BS
J Virol; 2004 Mar; 78(6):3014-23. PubMed ID: 14990720
[TBL] [Abstract][Full Text] [Related]
23. T-cells in respiratory syncytial virus (RSV) infection.
Askonas BA; Openshaw P; Cannon M
Adv Exp Med Biol; 1989; 257():9-17. PubMed ID: 2533461
[No Abstract] [Full Text] [Related]
24. Effect of respiratory syncytial virus infection on mice with protein malnutrition.
Peña-Cruz V; Reiss C; McIntosh K
J Med Virol; 1991 Apr; 33(4):219-23. PubMed ID: 1906929
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus.
Openshaw PJ
Clin Exp Immunol; 1989 Feb; 75(2):324-8. PubMed ID: 2784741
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T cell responses in lambs experimentally infected with bovine respiratory syncytial virus.
Sharma R; Woldehiwet Z
Vet Immunol Immunopathol; 1991 Jul; 28(3-4):237-46. PubMed ID: 1949569
[TBL] [Abstract][Full Text] [Related]
27. Comparison of lung histopathology and bronchoalveolar lavage cytology in mice and cotton rats infected with respiratory syncytial virus.
Vaux-Peretz F; Meignier B
Vaccine; 1990 Dec; 8(6):543-8. PubMed ID: 2087875
[TBL] [Abstract][Full Text] [Related]
28. Reinfection of mice with respiratory syncytial virus.
Graham BS; Bunton LA; Wright PF; Karzon DT
J Med Virol; 1991 May; 34(1):7-13. PubMed ID: 1885946
[TBL] [Abstract][Full Text] [Related]
29. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies protect against respiratory syncytial virus infection in mice.
Taylor G; Stott EJ; Bew M; Fernie BF; Cote PJ; Collins AP; Hughes M; Jebbett J
Immunology; 1984 May; 52(1):137-42. PubMed ID: 6201436
[TBL] [Abstract][Full Text] [Related]
31. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.
Johnson TR; Hong S; Van Kaer L; Koezuka Y; Graham BS
J Virol; 2002 May; 76(9):4294-303. PubMed ID: 11932395
[TBL] [Abstract][Full Text] [Related]
32. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease.
You D; Siefker DT; Shrestha B; Saravia J; Cormier SA
Respir Res; 2015 Aug; 16(1):91. PubMed ID: 26231396
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic T-cell response to respiratory syncytial virus in mice.
Bangham CR; Cannon MJ; Karzon DT; Askonas BA
J Virol; 1985 Oct; 56(1):55-9. PubMed ID: 2411951
[TBL] [Abstract][Full Text] [Related]
34. [Dynamics of local defensive reactions in the lungs in acute experimental inflammatory process induced by respiratory syncytial virus].
Voronina LM; Kop'eva TN; Makarova OV
Biull Eksp Biol Med; 1991 May; 111(5):512-5. PubMed ID: 1878569
[TBL] [Abstract][Full Text] [Related]
35. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
36. Respiratory syncytial virus infection in anti-mu-treated mice.
Graham BS; Bunton LA; Rowland J; Wright PF; Karzon DT
J Virol; 1991 Sep; 65(9):4936-42. PubMed ID: 1908028
[TBL] [Abstract][Full Text] [Related]
37. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated cytotoxic responses in lungs of cotton rats infected with respiratory syncytial virus.
Sun CS; Wyde PR; Wilson SZ; Knight V
Am Rev Respir Dis; 1983 Apr; 127(4):460-4. PubMed ID: 6340570
[TBL] [Abstract][Full Text] [Related]
39. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection.
Kumar M; Behera AK; Lockey RF; Zhang J; Bhullar G; De La Cruz CP; Chen LC; Leong KW; Huang SK; Mohapatra SS
Hum Gene Ther; 2002 Aug; 13(12):1415-25. PubMed ID: 12215263
[TBL] [Abstract][Full Text] [Related]
40. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice.
Lambert AL; Trasti FS; Mangum JB; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
